KOBIOLABS
LIVE

Serial Number

87603889

Owner

KOBIOLABS, INC.

Attorney

Hun Joon Kim

Filing Date

Sep 11, 2017

Add to watchlist:

No watchlists yet
View on USPTO

KOBIOLABS Trademark

Serial Number: 87603889 • Registration: 5791315

KOBIOLABS is a trademark filed by KOBIOLABS, INC. on September 11, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

KOBIOLABS, INC. (4 trademarks)

1, GWANAK-RO, GWANAK-GU
SEOUL 08826 , KR

Entity Type: 03

Trademark Details

Filing Date

September 11, 2017

Registration Date

July 2, 2019

Published for Opposition

April 16, 2019

Goods & Services

[ Pharmaceutical and veterinary preparations, namely, preparations for the prevention of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease; Microorganism preparations, namely, nutritive substances for microorganisms for medical or veterinary purposes; Microorganism preparations, namely, microorganism cells for medical or veterinary purposes; Cultures of microorganisms for medical purposes; Biological preparations for medical or veterinary purposes, namely, preparations for the treatment of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease; Dietetic food supplements; Dietetic foods adapted for medical purposes; Nutraceuticals for medical purposes, namely, for the treatment of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease ]

[ Consultation in the field of health risk assessment, namely, predicting health risks of individuals with regard to medical disease; ] Drug discovery services; [ Provision of scientific information and advice in the field of microorganisms; DNA testing for scientific research purposes; DNA analysis for scientific research purposes; DNA sequencing analysis for scientific research purposes; consultation and providing information in the fields of biomedicine for scientific and research purposes; Consultancy in analysis of biology sequence processing for medical research purposes; Consultancy in analysis of genomics for medical research purposes; ] scientific research in the fields of medicine, health and pharmacology [ ; Consultation and providing information in the fields of and pharmacology ]

[ Performing diagnosis of diseases; Provision of genetic testing for medical treatment purposes; Provision of gene therapy for medical treatment purposes; DNA screening for medical purposes; Consultation and providing information in the fields of medicine and health ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Oct 23, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 23, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 17, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Jun 16, 2025 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 27, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 27, 2024 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Nov 27, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 27, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 27, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 27, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 27, 2024 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 2, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 2, 2019 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 10, 2019 TCCA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 16, 2019 NPUB
PUBLISHED FOR OPPOSITION
Apr 16, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 27, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 28, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 25, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 5, 2018 GNRN
NON-FINAL ACTION E-MAILED
Sep 5, 2018 GNRT
NON-FINAL ACTION WRITTEN
Sep 5, 2018 CNRT
EXAMINER'S AMENDMENT ENTERED
Jun 19, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 19, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 19, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 19, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 9, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 8, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 8, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 21, 2017 GNRN
NON-FINAL ACTION E-MAILED
Dec 21, 2017 GNRT
NON-FINAL ACTION WRITTEN
Dec 21, 2017 CNRT
EXAMINER'S AMENDMENT ENTERED
Dec 18, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 18, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 18, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 18, 2017 CNEA
ASSIGNED TO EXAMINER
Dec 14, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 16, 2017 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2017 NWOS
NEW APPLICATION ENTERED
Sep 14, 2017 NWAP